A groundbreaking advancement in medical technology may soon replace the painful, invasive biopsies that millions of patients endure every year to diagnose and monitor life-threatening diseases like cancer and Alzheimer’s. Scientists at King’s College London have developed a patch equipped with nanoneedles—tiny structures 1,000 times thinner than a human hair—that can painlessly extract molecular information from tissue without damaging it.
The new device, described in the journal Nature Nanotechnology, marks a potential paradigm shift in diagnostic medicine. Unlike conventional biopsies, which involve cutting into the body to remove small samples of tissue, these nanoneedle patches can gather comprehensive cellular data without causing trauma or discomfort. This innovation is especially significant for patients with conditions that require repeated monitoring or occur in sensitive areas like the brain.
“We have been working on nanoneedles for 12 years, but this is our most exciting development yet,” said Dr. Ciro Chiappini, who led the study. “It opens a world of possibilities for people with brain cancer, Alzheimer’s, and for advancing personalized medicine. It will allow scientists – and eventually clinicians – to study disease in real time like never before.”
In preclinical trials, Dr. Chiappini’s team tested the patches on brain cancer tissue from human biopsies and mouse models. The results were remarkable. The nanoneedles successfully extracted what the researchers describe as “molecular fingerprints”—including proteins, lipids, and mRNA—from living cells, all without removing any physical part of the tissue. Because the tissue remains intact, the same site can be sampled repeatedly, offering an unprecedented opportunity for real-time disease tracking.
“This approach provides multidimensional molecular information from different types of cells within the same tissue,” explained Dr. Chiappini. “Traditional biopsies simply cannot do that. And because the process does not destroy the tissue, we can sample the same tissue multiple times, which was previously impossible.”
The technique is also fast. During brain surgery, for instance, surgeons could apply the patch to suspicious tissue and receive results within 20 minutes. That speed could be critical in determining whether tissue is cancerous and deciding how much to remove while minimizing damage to healthy areas.
The nanoneedles are fabricated using the same photolithography techniques used in computer chip manufacturing, which means they can be mass-produced at relatively low cost. This opens up the possibility of integrating them into everyday medical tools like bandages, endoscopes, and even contact lenses—devices already in direct contact with patients’ skin or internal tissues.
“This could be the beginning of the end for painful biopsies,” said Dr. Chiappini. “Our technology opens up new ways to diagnose and monitor disease safely and painlessly – helping doctors and patients make better, faster decisions.”
Traditional biopsies come with several drawbacks: they are invasive, can cause bleeding or infections, and are often painful—deterring patients from early testing or follow-up procedures. More importantly, the sample sizes they yield are often limited, which can hamper detailed diagnosis or treatment planning. Moreover, once tissue is removed, it cannot be sampled again. These limitations restrict how diseases can be studied and tracked over time.
By contrast, the nanoneedle patches allow clinicians to return to the same area for multiple, consistent readings. This is particularly important for chronic conditions like cancer or neurodegenerative diseases, where the course of treatment must be adapted regularly based on the body’s response.
Experts believe this technology could also accelerate the shift toward personalized medicine, in which treatment is tailored to each patient’s unique genetic and biochemical profile. With faster, less invasive tools, doctors can monitor how each individual responds to therapy and make real-time adjustments without subjecting patients to repeated painful procedures.
While the current findings are based on laboratory and preclinical tests, the researchers are optimistic about clinical trials in the near future. The non-destructive nature of the patch also means it could potentially be used for at-home monitoring in the future, offering patients more autonomy and reducing hospital visits.
In a field where innovation often arrives incrementally, the nanoneedle patch represents a significant leap forward. As research progresses, it could change not just how we diagnose disease, but how we understand and respond to it—gently, precisely, and in real time.
Recommended For You
